Martin Biel

Title: Martin Biel: Innovator in Gene Therapy

Introduction

Martin Biel is a prominent inventor based in Starnberg, Germany. He has made significant contributions to the field of gene therapy, particularly in the treatment of retinal degeneration diseases. With a total of 5 patents to his name, Biel's work is paving the way for innovative medical solutions.

Latest Patents

Biel's latest patents include groundbreaking inventions in the realm of adeno-associated viruses (AAV). One of his notable patents describes an AAV that comprises an insertion of at least 6-8 amino acids between specific positions of a defined sequence. This invention envisions the use of AAVs as a medicament and pharmaceutical compositions. Additionally, it outlines methods for in vitro use of AAV for transduction of retinal cells, as well as a method for screening insertion sequences. Another significant patent focuses on a polynucleotide designed for treating retinal degeneration diseases, such as retinitis pigmentosa. This patent includes a nucleic acid vector, pharmaceutical compositions, and methods for creating and utilizing these vectors in treatment.

Career Highlights

Throughout his career, Martin Biel has worked with notable companies, including Eyeserv GmbH and Vigeneron GmbH. His experience in these organizations has contributed to his expertise in gene therapy and innovative medical solutions.

Collaborations

Biel has collaborated with esteemed colleagues, including Stylianos Michalakis and Mathias Seeliger. These partnerships have further enhanced his research and development efforts in the field of gene therapy.

Conclusion

Martin Biel is a distinguished inventor whose work in gene therapy is making a significant impact on the treatment of retinal degeneration diseases. His innovative patents and collaborations reflect his commitment to advancing medical science.